Cristin Rothfuss
Vermögen: 2 Mio $ am 31.08.2026
Vermögen: 2 Mio $ am 31.08.2026
Cristin L.
Rothfuss is Executive Vice President & General Counsel at Sarepta Therapeutics, Inc. since 2026.
Formerly worked as Senior Associate Director at the Office of Technology Development.
Educated at Yale University (undergraduate) and Connecticut School of Law University Of (graduate).
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.09.2026 | 115 519 ( 0,11 % ) | 2 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | General Counsel | 01.02.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Finance |
Connecticut School of Law University Of
Connecticut School of Law University Of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen